Literature DB >> 2931376

Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: immunosuppression by adherent spleen cells.

A D Nickol, P F Bonventre.   

Abstract

Visceral leishmaniasis is one of several parasitic diseases of humans characterized by immune suppression. A murine model of disseminated leishmaniasis utilizing inbred strains of specific genetic constitution was used to study the mechanisms of immunosuppression elicited during the course of infection. Resistant (Lshr) and susceptible (Lshs) strains of mice were challenged with amastigotes of Leishmania donovani and evaluated as to immune status at intervals between 2 and 40 weeks after challenge. The proliferative responses of splenic lymphocytes to T-cell mitogens, a B-cell mitogen, and parasite antigens were measured to evaluate the relative immune status of parasitized mice and noninfected control mice. Lymphocytes from resistant C3Heb/FeJ (C3H) mice responded normally to concanavalin A and phytohemagglutinin throughout the course of infection. Parasite antigen responses appeared 2 weeks after challenge of C3H mice and remained vigorous for periods up to 6 months. In contrast, immune suppression during infection was profound in both the curing (C57B1/10) and noncuring (B10.D2) phenotypes of Lshs congenic mice. Both Lshs strains developed severe infection as evidenced by high parasite burdens in the liver and spleen 4 to 5 weeks after challenge; splenic lymphocytes taken from these mice between 2 and 8 weeks became increasingly unresponsive to the T-cell mitogens as well as to parasite antigens. The noncuring B10.D2 mice which suffered chronic infection continued to be suppressed for as long as 40 weeks. C57B1/10 (curing) mice, in contrast, cleared infection between 12 and 16 weeks. After spontaneous recovery or elimination of parasites by antimonial drug therapy, the response of spleen cells to T-cell mitogens or parasite antigens were restored to normal. The spleen cells from the Lshs strains of mice obtained during the height of infection suppressed the proliferative responses of spleen cells from their uninfected counterparts upon cocultivation in vitro. Removal of adherent cells from the suppressive spleen cell populations restored normal mitogen responses. On the basis of adherence characteristics, phagocytosis, and morphology, the suppressor was identified as a macrophage population which appears to be responsible for a nonspecific immunosuppression of Lshs mice with significant parasite burdens of L. donovani.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2931376      PMCID: PMC262151          DOI: 10.1128/iai.50.1.160-168.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse.

Authors:  D J Bradley; B A Taylor; J Blackwell; E P Evans; J Freeman
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

2.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

3.  Enhancing and suppressive effects of macrophages on T-lymphocyte stimulation in vitro.

Authors:  S Youdim
Journal:  Cell Immunol       Date:  1979-07       Impact factor: 4.868

4.  Effects of solid tumors on the resistance of mice to viral and bacterial infections.

Authors:  P F Bonventre; H C Bubel; J G Michael; A D Nickol
Journal:  Proc Soc Exp Biol Med       Date:  1982-02

5.  X-linked hypomaturation amelogenesis imperfecta: a case report.

Authors:  D L Good
Journal:  Dent Dimens       Date:  1980-06

6.  Influence of H-2 complex on acquired resistance to Leishmania donovani infection in mice.

Authors:  J Blackwell; J Freeman; D Bradley
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

7.  Elimination of Leishmania donovani amastigotes by activated macrophages.

Authors:  C G Haidaris; P F Bonventre
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

8.  Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation.

Authors:  Z Metzger; J T Hoffeld; J J Oppenheim
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

9.  Regulation of Leishmania populations within the host. II. genetic control of acute susceptibility of mice to Leishmania donovani infection.

Authors:  D J Bradley
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

10.  Suppressive activity of splenic adherent cells from Plasmodium chabaudi-infected mice.

Authors:  M Corrêa; P R Narayanan; H C Miller
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

View more
  13 in total

1.  Setting new immunobiological parameters in the hamster model of visceral leishmaniasis for in vivo testing of antileishmanial compounds.

Authors:  M A Dea-Ayuela; S Rama-Iñiguez; J M Alunda; F Bolás-Fernandez
Journal:  Vet Res Commun       Date:  2007-01-19       Impact factor: 2.459

2.  Characterization of protective T cells in the acquired response to Leishmania donovani in genetically determined cure (H-2b) and noncure (H-2d) mouse strains.

Authors:  O M Ulczak; E Ghadirian; E Skamene; J M Blackwell; P A Kongshavn
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

3.  Immunosuppression in hamsters with progressive visceral leishmaniasis is associated with an impairment of protein kinase C activity in their lymphocytes that can be partially reversed by okadaic acid or anti-transforming growth factor beta antibody.

Authors:  Ananda Mookerjee; Parimal C Sen; Asoke C Ghose
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

4.  Cyclosporin A treatment converts Leishmania donovani-infected C57BL/10 (curing) mice to a noncuring phenotype.

Authors:  L E Adinolfi; P F Bonventre
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

5.  Enhanced phagocytosis, killing, and serum sensitivity of Escherichia coli and Staphylococcus aureus treated with sub-MICs of imipenem.

Authors:  L E Adinolfi; P F Bonventre
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

6.  Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody.

Authors:  L Blanco; E M Choi; K Connolly; M R Thompson; P F Bonventre
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

7.  Influence of the Ity/Lsh/Bcg gene on the development of suppressor cell precursors in the early phase of the infection of mice with Mycobacterium lepraemurium.

Authors:  D Gosselin; R Turcotte; S Lemieux
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

8.  Recombinant interleukin-1 alpha augments granuloma formation and cytokine production but not parasite clearance in mice infected with Leishmania donovani.

Authors:  A J Curry; P M Kaye
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

9.  Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: T-lymphocyte-mediated immunosuppression.

Authors:  A D Nickol; P F Bonventre
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

10.  Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo.

Authors:  P F Bonventre; M R Thompson; L E Adinolfi; Z A Gillis; J Parsonnet
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.